NCI SBIR/STTR Grants
NCI offers different types of SBIR and STTR grant opportunities. Most grant requirements allow applications with an investigator-defined scope that is within the mission of the National Institutes of Health (NIH). NCI’s research areas of interest include:
- Therapeutics (e.g., small molecules, biologics, radiomodulators, and cell-based therapies)
- In vitro and in vivo diagnostics (e.g., companion diagnostics and prognostic technologies)
- Imaging technologies (e.g., agents, devices, and image-guided interventions)
- Devices for cancer therapy (e.g., interventional devices, surgical, radiation, and ablative therapies)
- Tools for cancer biology research
- Technologies and agents for cancer prevention
- Technologies for cancer control (e.g., behavioral health interventions, tools for genetic, epidemiologic, behavioral, social, and/or surveillance cancer research)
- Digital health (e.g., mobile health, health information, technology, and bioinformatics)
Types of NCI SBIR/STTR Grant Funding Opportunities
-
NCI SBIR/STTR Grant Parent Solicitations
Find Grant Parent Solicitation opportunities for small business innovation research.
-
Small Business Transition Grant for New Entrepreneurs
Support the transfer of technology from academic laboratories into small businesses.
-
Commercialization Readiness Pilot (CRP) Program
The Commercialization Readiness Pilot (CRP) Program helps small businesses with NIH-funded SBIR or STTR projects bridge the gap between late-stage research and a commercially viable product.
-
Phase IIB Strategic Breakthrough Award
The Phase IIB Strategic Breakthrough Award is a first-of-its-kind funding mechanism designed to accelerate late-stage clinical development of therapeutic and medical device technologies addressing pediatric and rare cancers.